222 related articles for article (PubMed ID: 18264714)
1. Subcutaneous injection, from birth, of epigallocatechin-3-gallate, a component of green tea, limits the onset of muscular dystrophy in mdx mice: a quantitative histological, immunohistochemical and electrophysiological study.
Nakae Y; Hirasaka K; Goto J; Nikawa T; Shono M; Yoshida M; Stoward PJ
Histochem Cell Biol; 2008 Apr; 129(4):489-501. PubMed ID: 18264714
[TBL] [Abstract][Full Text] [Related]
2. Green tea extract and its major polyphenol (-)-epigallocatechin gallate improve muscle function in a mouse model for Duchenne muscular dystrophy.
Dorchies OM; Wagner S; Vuadens O; Waldhauser K; Buetler TM; Kucera P; Ruegg UT
Am J Physiol Cell Physiol; 2006 Feb; 290(2):C616-25. PubMed ID: 16403950
[TBL] [Abstract][Full Text] [Related]
3. Quantitative evaluation of the beneficial effects in the mdx mouse of epigallocatechin gallate, an antioxidant polyphenol from green tea.
Nakae Y; Dorchies OM; Stoward PJ; Zimmermann BF; Ritter C; Ruegg UT
Histochem Cell Biol; 2012 Jun; 137(6):811-27. PubMed ID: 22331205
[TBL] [Abstract][Full Text] [Related]
4. Early onset of lipofuscin accumulation in dystrophin-deficient skeletal muscles of DMD patients and mdx mice.
Nakae Y; Stoward PJ; Kashiyama T; Shono M; Akagi A; Matsuzaki T; Nonaka I
J Mol Histol; 2004 Jun; 35(5):489-99. PubMed ID: 15571326
[TBL] [Abstract][Full Text] [Related]
5. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS
Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351
[TBL] [Abstract][Full Text] [Related]
6. Muscle specific kinase protects dystrophic mdx mouse muscles from eccentric contraction-induced loss of force-producing capacity.
Trajanovska S; Ban J; Huang J; Gregorevic P; Morsch M; Allen DG; Phillips WD
J Physiol; 2019 Sep; 597(18):4831-4850. PubMed ID: 31340406
[TBL] [Abstract][Full Text] [Related]
7. Exercise increases utrophin protein expression in the mdx mouse model of Duchenne muscular dystrophy.
Gordon BS; Lowe DA; Kostek MC
Muscle Nerve; 2014 Jun; 49(6):915-8. PubMed ID: 24375286
[TBL] [Abstract][Full Text] [Related]
8. Satellite cells and utrophin are not directly correlated with the degree of skeletal muscle damage in mdx mice.
Yamane A; Akutsu S; Diekwisch TG; Matsuda R
Am J Physiol Cell Physiol; 2005 Jul; 289(1):C42-8. PubMed ID: 15703201
[TBL] [Abstract][Full Text] [Related]
9. Endurance capacity in maturing mdx mice is markedly enhanced by combined voluntary wheel running and green tea extract.
Call JA; Voelker KA; Wolff AV; McMillan RP; Evans NP; Hulver MW; Talmadge RJ; Grange RW
J Appl Physiol (1985); 2008 Sep; 105(3):923-32. PubMed ID: 18583385
[TBL] [Abstract][Full Text] [Related]
10. Expression of a NOS transgene in dystrophin-deficient muscle reduces muscle membrane damage without increasing the expression of membrane-associated cytoskeletal proteins.
Tidball JG; Wehling-Henricks M
Mol Genet Metab; 2004 Aug; 82(4):312-20. PubMed ID: 15308129
[TBL] [Abstract][Full Text] [Related]
11. Celecoxib treatment improves muscle function in mdx mice and increases utrophin A expression.
Péladeau C; Adam NJ; Jasmin BJ
FASEB J; 2018 Sep; 32(9):5090-5103. PubMed ID: 29723037
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-206 is overexpressed in the diaphragm but not the hindlimb muscle of mdx mouse.
McCarthy JJ; Esser KA; Andrade FH
Am J Physiol Cell Physiol; 2007 Jul; 293(1):C451-7. PubMed ID: 17459947
[TBL] [Abstract][Full Text] [Related]
13. Xanthine oxidase is hyper-active in Duchenne muscular dystrophy.
Lindsay A; McCourt PM; Karachunski P; Lowe DA; Ervasti JM
Free Radic Biol Med; 2018 Dec; 129():364-371. PubMed ID: 30312761
[TBL] [Abstract][Full Text] [Related]
14. Enhanced expression of the alpha 7 beta 1 integrin reduces muscular dystrophy and restores viability in dystrophic mice.
Burkin DJ; Wallace GQ; Nicol KJ; Kaufman DJ; Kaufman SJ
J Cell Biol; 2001 Mar; 152(6):1207-18. PubMed ID: 11257121
[TBL] [Abstract][Full Text] [Related]
15. Ixazomib, an oral proteasome inhibitor, exhibits potential effect in dystrophin-deficient mdx mice.
Micheletto MLJ; Hermes TA; Bertassoli BM; Petri G; Perez MM; Fonseca FLA; Carvalho AAS; Feder D
Int J Exp Pathol; 2021 Feb; 102(1):11-21. PubMed ID: 33296126
[TBL] [Abstract][Full Text] [Related]
16. Comparative proteomic profiling of soleus, extensor digitorum longus, flexor digitorum brevis and interosseus muscles from the mdx mouse model of Duchenne muscular dystrophy.
Carberry S; Brinkmeier H; Zhang Y; Winkler CK; Ohlendieck K
Int J Mol Med; 2013 Sep; 32(3):544-56. PubMed ID: 23828267
[TBL] [Abstract][Full Text] [Related]
17. Beneficial cilostazol therapeutic effects in mdx dystrophic skeletal muscle.
Hermes Tde A; Macedo AB; Fogaça AR; Moraes LH; de Faria FM; Kido LA; Cagnon VH; Minatel E
Clin Exp Pharmacol Physiol; 2016 Feb; 43(2):259-67. PubMed ID: 26639107
[TBL] [Abstract][Full Text] [Related]
18. Comparison of skeletal muscle pathology and motor function of dystrophin and utrophin deficient mouse strains.
van Putten M; Kumar D; Hulsker M; Hoogaars WM; Plomp JJ; van Opstal A; van Iterson M; Admiraal P; van Ommen GJ; 't Hoen PA; Aartsma-Rus A
Neuromuscul Disord; 2012 May; 22(5):406-17. PubMed ID: 22284942
[TBL] [Abstract][Full Text] [Related]
19. Vector-mediated expression of muscle specific kinase restores specific force to muscles in the mdx mouse model of Duchenne muscular dystrophy.
Ban J; Beqaj B; Phillips WD
Exp Physiol; 2021 Aug; 106(8):1794-1805. PubMed ID: 34114278
[TBL] [Abstract][Full Text] [Related]
20. Expression of utrophin at dystrophin-deficient neuromuscular synapses of mdx mice: a study of protected and affected muscles.
Ferretti R; Neto HS; Marques MJ
Anat Rec (Hoboken); 2011 Feb; 294(2):283-6. PubMed ID: 21235003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
